All the news

Showing 10 of 102 articles from: Treatment outcomes

Get an RSS feed of these articles

Show

DDW 2013: Viral Breakthrough May Occur during Interferon/Ribavirin 'Tail' of HCV Triple Therapy

HIVandhepatitis.com / 30 May 2013
Investigational noninterferon HCV treatment effective across patient groups

Internal Medicine News / 30 May 2013
SVR associated with lower risk for diabetes in HCV

Healio Hepatology / 21 May 2013
HCV patients with late viral breakthrough have similar characteristics

Healio Hepatology / 20 May 2013
Ribavirin Trough Affects Early HCV Response With Unfavorable IL28B Profile

NATAP / 14 May 2013
IL28B genotype had limited effect on telaprevir response in HCV patients

Healio Hepatology / 06 February 2013
AASLD Updated Practice Guideline: Use and Interpretation of HCV RNA Results During Triple Therapy

Manual Items / 15 January 2013
Support improves hepatitis C treatment completion and response rates among drug users

Michael Carter / 02 January 2013

Hepatitis C treatment completion and response rates among injecting drug users are similar to those seen in general patient populations, the findings of a meta-analysis published in the online edition of Clinical Infectious ...
Low viral load in hepatitis C treatment: Is a third drug necessary?

Rob Camp / 23 November 2012

When resources for hepatitis C treatment with new directly acting antivirals are limited, findings from the United States suggest that previously untreated people with low viral loads may stand a good chance ...
Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients

Michael Carter / 11 October 2012

Vitamin D deficiency is associated with a poorer response to hepatitis C therapy in people who are co-infected with HIV and hepatitis C, investigators report in the online edition of AIDS. Austrian ...